|
Download
PDF
|
Emerging Clinical Trial Locations
Pharma and biotech companies are attempting to combat escalating
R&D costs and lengthy clinical trial timelines by improving
patient recruitment and the efficiency of clinical trial
analysis/reporting. The biopharmaceutical market has recognized
the opportunities and advantages that exist by conducting
clinical trials in emerging markets. Although these markets
offer a number of significant benefits over traditional clinical
trial settings, there remain a variety of challenges and
problems associated with conducting trials in emerging regions.
‘Emerging Clinical Trial Locations’ is a new report published by
Business Insights that provides a comprehensive examination of
the clinical trial landscape in emerging countries, with
specific focus on China, India, Central and Eastern Europe and
Latin America. It identifies the major drivers and barriers to
conducting clinical trials in emerging regions and profiles key
issues for consideration when selecting a trial site. For each
featured region, this report provides an assessment of pharma
market dynamics, the healthcare system and CRO-related
infrastructure, leading CROs established within the region and
the regulatory and legislative frameworks that govern the
conduct of clinical trials.
Published: June 2009 - Global.
View
Table Of Contents >
|
